Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Adherex Technologies’ PEDMARK Push Targets Larger AYA Market After Record Quarter

Fennec Pharmaceuticals (NASDAQ:FENC) executives outlined the company’s commercial strategy for PEDMARK, its sodium thiosulfate product used to prevent cisplatin-related hearing loss, during a fireside chat at the H.C. Wainwright 4th Annual BioConnect Investor Conference. Ram Selvaraju, managing dir

MarketBeat

HubSpot at 2019 Levels Is an Opportunity—Not a Warning

HubSpot's stock says 2019 but its fundamentals say 2026 - that's a gap that's starting to look impossible for the market to keep ignoring.

MarketBeat

Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?

Deckers posted record earnings and revenue, but investors are weighing HOKA and UGG strength against slowing growth and brand concentration risk

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally

Kiniksa Pharmaceuticals is gaining momentum after strong ARCALYST sales growth, raised revenue guidance, and optimism surrounding its next-generation pipeline

MarketBeat

Expedia Group Marks 30 Years With AI Push, Uber and CLEAR Partnerships

Expedia Group (NASDAQ:EXPE) used a company event marking 30 years of Expedia to outline new partnerships, artificial intelligence initiatives and partner tools aimed at increasing traveler demand and simplifying travel operations. CEO Ariane Gorin said the company’s purpose remains “to help travele

MarketBeat

MarketBeat Week in Review – 05/18 - 05/22

Stocks were up sharply to end the week as NVIDIA’s forward guidance showed tangible demand to support AI infrastructure and overshadowed mixed retail reports

MarketBeat

Exelixis Eyes CABO Growth as Zanzalintinib Readouts and Potential CRC Launch Near

Exelixis (NASDAQ:EXEL) remains focused on expanding its CABO franchise while preparing for potential launches and data readouts tied to zanzalintinib, Andrew Peters, the company’s senior vice president of strategy, said during a session hosted by RBC Capital Markets. Peters said Exelixis’ guidance

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Enlight Renewable Energy Targets AI Data Centers, $2.1B Revenue Run Rate by 2028

Enlight Renewable Energy (NASDAQ:ENLT) used its 2026 Investor Day to outline its long-term growth strategy, emphasizing renewable power demand, expansion in the United States and Europe, operational execution and a new push into data center development. Itay Banayan, Enlight’s chief corporate devel

MarketBeat

Euronet Worldwide Pitches Payments Platform Shift, Targets 10%-15% EPS Growth

Euronet Worldwide (NASDAQ:EEFT) used its 2026 Investor Day to reposition its business as a global payments platform built around shared technology, cross-segment distribution and digital growth initiatives, while management laid out a multi-year outlook calling for continued earnings growth and marg

MarketBeat

Definium Therapeutics Eyes Key DT-120 Depression Data, Advances Anxiety Program

Definium Therapeutics (NASDAQ:DFTX) Chief Financial Officer Brandi Roberts said the company is preparing for several key clinical and regulatory milestones for DT-120, including anticipated Phase III data in major depressive disorder later this quarter and ongoing Phase III work in generalized anxie

MarketBeat

Datadog CEO Touts AI, Cloud Migration as Revenue Growth Accelerates

Datadog (NASDAQ:DDOG) CEO and co-founder Olivier Pomel said the company is benefiting from both ongoing cloud migration and the rapid expansion of artificial intelligence workloads, describing the observability and security provider as still early in a long-running market cycle. Speaking at a compa

MarketBeat

Cytokinetics Says MYKORZO Launch Tops Expectations as HCM Data Draws Praise

Cytokinetics (NASDAQ:CYTK) executives said the commercial launch of MYKORZO is tracking ahead of internal expectations, while also highlighting positive physician feedback on the drug’s label, REMS program and recent clinical data in hypertrophic cardiomyopathy during a discussion hosted by RBC Capi

MarketBeat

Crexendo Says It’s on Track for $100M Revenue as AI and Acquisitions Fuel Growth

Crexendo (NASDAQ:CXDO) President and Chief Operating Officer Doug Gaylor told investors at an LD Micro presentation that the cloud communications company is on track for sharply higher revenue and is continuing to grow profitably while pursuing acquisitions among its software licensee base. Gaylor

MarketBeat

Cavco Industries Q4 Earnings Call Highlights

Cavco Industries (NASDAQ:CVCO) reported higher fourth-quarter revenue and profit compared with the prior year, while management said orders strengthened late in the period and backlogs improved heading into the new fiscal year. On the company’s fiscal fourth-quarter earnings call, President and CEO

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Global Ship Lease Q1 Earnings Call Highlights

Global Ship Lease (NYSE:GSL) executives said the container ship lessor entered 2026 with full charter coverage for the year, a strengthened balance sheet and more than $2 billion in contracted revenue, while warning that escalating geopolitical disruptions are reshaping global trade routes and vesse

MarketBeat

Bicara Therapeutics ASCO Data Bolster Ficerafusp Alfa in Head and Neck Cancer

Bicara Therapeutics (NASDAQ:BCAX) said new data to be presented at the 2026 American Society of Clinical Oncology annual meeting support the clinical profile of ficerafusp alfa, also referred to by the company as Ficara, in first-line recurrent or metastatic HPV-negative head and neck cancer. On an

MarketBeat

Frontline Q1 Earnings Call Highlights

Frontline (NYSE:FRO) reported what Chief Executive Officer Lars Barstad called the company’s most profitable quarter since 2004, as tanker markets were reshaped by the effective closure of the Strait of Hormuz and shifting global oil trade patterns. Speaking on the company’s first-quarter 2026 earn

MarketBeat

Flowers Foods Q1 Earnings Call Highlights

Flowers Foods (NYSE:FLO) said it delivered first-quarter bottom-line results ahead of expectations despite softer sales trends and continued pressure in the traditional bread category, as management pointed to brand investment, cost controls and balance sheet priorities as key themes for the rest of

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Imperial Petroleum Q1 Earnings Call Highlights

Imperial Petroleum (NASDAQ:IMPP) reported sharply higher first-quarter 2026 results, with management saying the company benefited from a larger fleet and a surge in tanker rates tied to geopolitical disruptions in the Middle East. Chief Executive Officer Harry Vafias said the quarter marked the com

MarketBeat

SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?

SpaceX filed its S-1 ahead of a historic June IPO. Here’s what investors should know about Starlink, valuation risks, and Elon Musk’s governance.

MarketBeat

CAVA Group’s Stock Looks Delicious After Strong Earnings

CAVA stock surged after the company posted strong Q1 earnings, raised guidance, and delivered impressive same-store sales growth despite valuation concerns

MarketBeat

ProSiebenSat.1 Media AGM Puts Entertainment Pivot, Cost Cuts in Spotlight

ProSiebenSat.1 Media (ETR:PSM) used its annual general meeting to outline a sharper focus on entertainment, tighter financial discipline and continued cost reductions following a year marked by weak advertising markets, portfolio disposals and a change in control after MFE became majority shareholde

MarketBeat

CAE Q4 Earnings Call Highlights

CAE (NYSE:CAE) reported higher fourth-quarter and full-year revenue for fiscal 2026, but management said weaker civil aviation training conditions, disruption tied to the Middle East conflict and transformation-related costs weighed on profitability and will continue to affect the company’s near-ter

MarketBeat

Booz Allen Hamilton Q4 Earnings Call Highlights

Booz Allen Hamilton (NYSE:BAH) executives said the government technology contractor exited what Chief Executive Horacio Rozanski called its “most challenging year” as a public company with stronger profitability than expected, even as revenue declined because of weakness in its civil business. On t

MarketBeat

BJ's Wholesale Club Q1 Earnings Call Highlights

BJ's Wholesale Club (NYSE:BJ) reported a solid start to fiscal 2026, with management pointing to membership gains, higher fuel volumes, digital adoption and new club openings as key drivers of first-quarter performance. Chairman and Chief Executive Officer Bob Eddy said the retailer’s results were

1 … 25 26 27 28

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.